128940 — Hanmi Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Market Cap
KR₩4tn
Enterprise Value
KR₩5tn
Revenue
KR₩1tn

Annual balance sheet for Hanmi Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	148,032	209,310	235,540	254,156	192,388
Net Total Accounts Receivable
Net Total Receivables	152,838	225,276	183,439	179,003	239,277
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	614,373	703,962	694,158	730,624	746,306
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,000,040	957,218	917,982	860,242	822,496
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,882,027	1,936,729	1,924,586	1,898,668	2,020,840
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	533,451	648,938	676,748	704,763	682,759
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	1,152,039	1,133,815	1,052,720	943,226	935,947
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	729,987	802,914	871,866	955,442	1,084,893
Total Liabilities & Shareholders' Equity	1,882,027	1,936,729	1,924,586	1,898,668	2,020,840
Total Common Shares Outstanding